- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,023GBP
- Report
- July 2024
- 164 Pages
Global
From €5195EUR$5,450USD£4,385GBP
- Report
- July 2024
- 142 Pages
Global
From €3716EUR$3,899USD£3,137GBP
- Report
- January 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,339GBP
- Report
- July 2024
- 121 Pages
North America
From €3526EUR$3,699USD£2,976GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Report
- October 2023
- 186 Pages
Global
From €5242EUR$5,500USD£4,425GBP
- Report
- June 2024
- 185 Pages
Global
From €3755EUR$3,939USD£3,169GBP
- Report
- June 2024
- 182 Pages
Global
From €3755EUR$3,939USD£3,169GBP
- Report
- March 2024
- 194 Pages
Global
From €3755EUR$3,939USD£3,169GBP
- Report
- October 2023
- 75 Pages
Global
From €5671EUR$5,950USD£4,787GBP
- Report
- March 2024
- 195 Pages
Global
From €3755EUR$3,939USD£3,169GBP
- Report
- January 2024
- 150 Pages
Global
From €4623EUR$4,850USD£3,902GBP
- Report
- October 2023
- 185 Pages
Global
From €4671EUR$4,900USD£3,942GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Report
- May 2024
- 134 Pages
Global
From €6195EUR$6,499USD£5,229GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more